Therefore, targeting CXCR4 slows tumour growth, reduces angiogenesis as well as the expression of VEGF [9] and increases the sensitivity of malignancies to chemotherapy, leading to apoptosis [4,120]. Here, CXCR4 is linked to neoplasm.